Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Despite Global Financial Crisis, China Pharma Market Expected To Grow At 20% Over Next Several Years

This article was originally published in PharmAsia News

Executive Summary

SHANGHAI - Despite the financial downturn, IMS China recently reported a 26 percent increase in growth for China's pharmaceutical market in 2008, bringing the total size of the market to approximately $25 billion. The growth rate is expected to hold steady at around 20 percent for the next several years, according to IMS Health analysts

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

SC071286

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel